Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

60
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
60
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

31
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
31
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

39
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
39
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

36
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
36
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

54
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
54
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

71
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
71

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Left Atrial Stiffness Index and Outcomes After Discharge in Heart Failure With Preserved Ejection Fraction.

JACC. Asia·2026
Same author

Risk of Long-Term Clozapine Medication over Decades for Cardiac Adverse Events Including Heart Failure and Its Pathophysiology: A Japan and China Retrospective Cohort Analysis.

Medical sciences (Basel, Switzerland)·2026
Same author

Sex Differences in Characteristics and Outcomes Among Patients With Hypertrophic Cardiomyopathy: Insights From the REVEAL-HCM Study.

Journal of the American Heart Association·2026
Same author

Ephedrine-Triggered Torsades de Pointes in Two Patients Following Desflurane-Induced QT Prolongation.

Journal of arrhythmia·2026
Same author

Progressive Enlargement of a Coronary Artery Communication With an Atrial Septal Defect Closure Device.

JACC. Case reports·2026
Same author

Giant Hemorrhagic Pericardial Cyst Mimicking Primary Cardiac Lymphoma by Coronary Artery Encasement.

Circulation. Cardiovascular imaging·2026

Related Experiment Video

Updated: Sep 23, 2025

A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice
06:54

A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice

Published on: June 22, 2022

2.9K

Moyamoya Disease Complicating Ebstein's Anomaly.

Itaru Goto1, Ryuji Okamoto2,3, Yu Sato4

  • 1Department of Cardiology, Matsusaka Chuo General Hospital, Japan.

Internal Medicine (Tokyo, Japan)
|May 15, 2022
PubMed
Summary

Ebstein's anomaly, a rare heart condition, can coexist with moyamoya disease, leading to stroke. This case highlights the importance of considering this rare concurrence in heart failure patients to prevent brain injury.

Keywords:
Ebstein's anomalycerebral infarctionheart failuremoyamoya disease

More Related Videos

Author Spotlight: Studying Clinical Characters and Epilepsy Outcomes After Frontal Disconnection in Patients with MOGHE
06:04

Author Spotlight: Studying Clinical Characters and Epilepsy Outcomes After Frontal Disconnection in Patients with MOGHE

Published on: August 16, 2024

1.1K
Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA
13:10

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA

Published on: April 24, 2017

18.7K

Related Experiment Videos

Last Updated: Sep 23, 2025

A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice
06:54

A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice

Published on: June 22, 2022

2.9K
Author Spotlight: Studying Clinical Characters and Epilepsy Outcomes After Frontal Disconnection in Patients with MOGHE
06:04

Author Spotlight: Studying Clinical Characters and Epilepsy Outcomes After Frontal Disconnection in Patients with MOGHE

Published on: August 16, 2024

1.1K
Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA
13:10

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA

Published on: April 24, 2017

18.7K

Area of Science:

  • Cardiology
  • Neurology
  • Vascular Medicine

Background:

  • Ebstein's anomaly is a rare congenital heart defect impacting the tricuspid valve.
  • Heart failure is a potential complication of Ebstein's anomaly.

Observation:

  • A 38-year-old woman with Ebstein's anomaly presented with altered consciousness and sensory disturbances during heart failure treatment.
  • Imaging revealed acute cerebral infarction and internal carotid artery obstruction, indicative of moyamoya disease.

Findings:

  • The patient was diagnosed with multiple cerebral infarctions secondary to concomitant Ebstein's anomaly and moyamoya disease.
  • This dual diagnosis is exceptionally rare, presenting unique clinical challenges.

Implications:

  • Clinicians treating Ebstein's anomaly patients with heart failure must consider the possibility of concurrent moyamoya disease.
  • Avoiding aggressive diuresis and vasodilation is crucial to prevent irreversible neurological damage in such cases.